Percutaneous ethanol injection for hepatocellular carcinoma: 20-year outcome and prognostic factors - Wikidata - wikimedia - TriplyDB

Percutaneous ethanol injection for hepatocellular carcinoma: 20-year outcome and prognostic factors

Percutaneous ethanol injection for hepatocellular carcinoma: 20-year outcome and prognostic factors

http://www.wikidata.org/entity/Q24630594

about

Evolving ablative therapies for hepatic malignancy Hepatocellular Carcinoma: The Role of Interventional Oncology Dosimetric comparison of volumetric modulated arc therapy with robotic stereotactic radiation therapy in hepatocellular carcinoma.Natural interferon-beta treatment for patients with chronic hepatitis C in Japan Current management of patients with hepatocellular carcinoma.Gated Volumetric-Modulated Arc Therapy vs. Tumor-Tracking CyberKnife Radiotherapy as Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: A Dosimetric Comparison Study Focused on the Impact of Respiratory Motion Managements.Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study Acquired amegakaryocytic thrombocytopenic purpura induced by percutaneous ethanol injection during treatment of hepatocellular carcinoma: A case report.Hepatocellular carcinoma in patients with chronic kidney disease A short review of basic head and neck interventional procedures in a general radiology department.Advantages of Laparoscopic Radiofrequency Ablation Over Percutaneous Radiofrequency Ablation in Hepatocellular Carcinoma.Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.Hepatocellular carcinoma in hemodialysis patients.Alcoholization of pyogenichepatic abscess with absolute alcohol in Bama minipigs.Effect of nucleoside analog use in patients with hepatitis B virus-related hepatocellular carcinoma.Conservative management of cesarean scar pregnancy by local injection of ethanol under hysteroscopic guidance.The 6th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2015): Evidence and Consensus on HCC Management.Salvage treatment for local recurrence of hepatocellular carcinoma after local ablation therapy.Combined radiofrequency ablation and ethanol injection with a multipronged needle for the treatment of medium and large hepatocellular carcinoma.The effects of percutaneous ethanol injection followed by 20-kHz ultrasound and microbubbles on rabbit hepatic tumors.Recent Advances in the Image-Guided Tumor Ablation of Liver Malignancies: Radiofrequency Ablation with Multiple Electrodes, Real-Time Multimodality Fusion Imaging, and New Energy Sources.Percutaneous Ablation for Hepatocellular Carcinoma: Comparison of Various Ablation Techniques and Surgery.

P2860

Q27002551-B7679E48-399E-4DDB-8B46-329D7ADE4D46 Q28071444-961D5202-EEE2-4D4A-8ABB-D1C3D4F0EC22 Q30401016-BCF9073B-F85C-426C-AD66-0358BEE66969 Q35668734-BC0BEFC0-CC4B-435B-A628-0D969DFA1089 Q35895363-81B5D11F-9204-4A8B-A818-99A7214CFB40 Q36201159-D69AAB90-75CF-47F5-A26E-C927F11B27E2 Q36404761-4FD4A23A-C21E-4431-AAAC-BD141B218DC8 Q36502787-E9114CAF-9A55-4D39-A5AB-E699F2D734AE Q36821615-C772D6C3-B0DD-4961-89C9-A9FC99DC69D5 Q38170967-94B1A32A-444D-4BDF-9D55-98754D7CEF7D Q38400801-5A9CCF80-C9AB-4D99-91D6-710FB66174E3 Q41962614-6AC10E2D-8835-49F5-B569-E1502585149A Q42654107-8F5E32C4-79C4-448E-8767-7B0E3B94F536 Q42675809-CD35E7B3-B2EE-4ED3-94B2-A6968F8ABF61 Q44256705-79A66FFF-A508-4034-B1A4-347F2DA89652 Q45895064-069CBDC0-DB1A-4D1B-9253-024110F70EAF Q46027563-8E4A6DDF-6F7A-4231-927B-426930D03E66 Q50478924-BE4168A3-B14F-4CA0-8252-3606B5F443C0 Q51738380-941B39E0-C24E-4A3E-93FA-A144863E0643 Q51795863-F2C008B8-64CE-4E0C-85DD-20CBB402CFB2 Q55349038-01D1D0A0-E1DB-40A3-B5B2-4D4F9987D2D3 Q55487080-D90126CC-3ED6-4979-BDBB-B06F5CA84CDD

P2860

Percutaneous ethanol injection for hepatocellular carcinoma: 20-year outcome and prognostic factors

http://www.wikidata.org/entity/Q24630594

description

2012 nî lūn-bûn

@nan

2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Percutaneous ethanol injection ...... outcome and prognostic factors

@ast

Percutaneous ethanol injection ...... outcome and prognostic factors

@en

Percutaneous ethanol injection ...... outcome and prognostic factors

@nl

type

label

Percutaneous ethanol injection ...... outcome and prognostic factors

@ast

Percutaneous ethanol injection ...... outcome and prognostic factors

@en

Percutaneous ethanol injection ...... outcome and prognostic factors

@nl

prefLabel

Percutaneous ethanol injection ...... outcome and prognostic factors

@ast

Percutaneous ethanol injection ...... outcome and prognostic factors

@en

Percutaneous ethanol injection ...... outcome and prognostic factors

@nl

P1433

Q24630594-749E5A91-5E73-4FD0-8C6F-11975385E628

P1476

Q24630594-AEBFE4E1-B959-4F2B-955E-E6B77DC3A5FA

P2093

Q24630594-02F73D51-659D-40CC-80C5-73C1BDBBD5F0

Q24630594-1E8F5372-CBB3-4EC1-949B-A3738A843EFD

Q24630594-263C76C7-D68F-4711-8DCE-94E902D3579F

Q24630594-5EFB9DB4-40A7-4D41-9AAC-3BE1F41E441B

Q24630594-60FDBCDA-7FB3-4844-A5CE-C315C7B7E949

Q24630594-BF5F494C-EEA3-4334-9584-5CF9B8FC3C30

Q24630594-BF62BC6F-32DC-4209-A975-FC1BC66824C4

Q24630594-D03491A2-062F-4B82-9F11-B708D2E1EBD3

Q24630594-F3F46CF0-D438-484F-97D3-B9B958603891

Q24630594-F81B1511-2B04-4C67-B4A9-8A937FE3CB07

P2860

Q24630594-08951D9E-2608-43D0-9CFA-9427ED81A7C2

Q24630594-17BF9B35-D16C-41BA-93BF-93F24D070CD3

Q24630594-1AE432C6-9294-40CD-9E82-CD0843E93067

Q24630594-305583B4-D13B-4976-BE96-759070F2256D

Q24630594-33B26AF1-C6D2-40D0-8FF1-E3A7AE53F42A

Q24630594-3AD00A71-57F4-4DC1-897B-294C68C5FD7F

Q24630594-4B6F6E4E-127F-4ED6-98EF-7710E94A9152

Q24630594-5B2504B4-9609-4C19-AFE2-88681A610F60

Q24630594-66F9DBB8-74E1-44BD-9A66-D7EC284E3F03

Q24630594-7EFB6A43-749A-410C-B239-597E5EFAA4C1

P304

Q24630594-8ADC1E38-5D60-4E11-B3F2-6FAABD33C692

P31

Q24630594-E171758E-46CF-4ED8-819C-F7550492C71E

P356

Q24630594-7CA1223B-EDF9-4E52-B36B-CAA33A305EDB

P407

Q24630594-F51D8452-CD1E-4646-A80A-3662B62DFB47

P433

Q24630594-9D788DB9-EAF3-4B46-BB27-DA2BB5B3B71D

P478

Q24630594-698EC498-5024-49D5-9EB4-0DCB33C84968

P50

Q24630594-698719EF-E703-4FBD-85FF-0CCCFD2B3202

P577

Q24630594-8FF1A6E6-C0BE-4D03-80BF-9345B231EB83

P5875

Q24630594-3B9E8C93-F928-4CAC-8FAA-3CA91787AE0F

P698

Q24630594-9D7FC853-9F2F-4D0E-B502-0ECE15F3DF26

P921

Q24630594-E8FA579D-DB8A-4789-A227-31764BD3D792

P932

Q24630594-C5AAD785-FBF0-4D83-B319-2162E2A1DB8C

P356

J.1478-3231.2012.02838.X

P1433

Liver International

P1476

Percutaneous ethanol injection ...... outcome and prognostic factors

@en

P2093

Fumihiko Kanai

http://www.w3.org/2001/XMLSchema#string

Haruhiko Yoshida

http://www.w3.org/2001/XMLSchema#string

Masao Omata

http://www.w3.org/2001/XMLSchema#string

Masatoshi Imamura

http://www.w3.org/2001/XMLSchema#string

Naoya Kato

http://www.w3.org/2001/XMLSchema#string

Ryosuke Tateishi

http://www.w3.org/2001/XMLSchema#string

Shinpei Sato

http://www.w3.org/2001/XMLSchema#string

Shuichiro Shiina

http://www.w3.org/2001/XMLSchema#string

Shuntaro Obi

http://www.w3.org/2001/XMLSchema#string

Takuma Teratani

http://www.w3.org/2001/XMLSchema#string

P2860

Management of hepatocellular carcinoma

Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors.

Image-guided tumor ablation: standardization of terminology and reporting criteria

Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan.

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation.

Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection.

Nonsurgical treatment of hepatocellular carcinoma: from percutaneous ethanol injection therapy and percutaneous microwave coagulation therapy to radiofrequency ablation.

Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma.

Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm.

A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma.

P304

1434-42

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1478-3231.2012.02838.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

227393361

http://www.w3.org/2001/XMLSchema#string

P698

22712520

http://www.w3.org/2001/XMLSchema#string

P921

P932

3466412

http://www.w3.org/2001/XMLSchema#string